Abrogation of TGF-β activity during retroviral transduction improves murine hematopoietic progenitor and repopulating cell gene transfer efficiency

Gene Therapy

Volumn 5, Issue 9, 1998, Pages 1265-1271

  Yu, J ^a   Soma, T ^a   Hanazono, Y ^a   Dunbar, C E ^a,b  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

In vivo; Inhibitory cytokine; Murine; Retroviral; Stem cell; Transforming growth factor

Indexed keywords

INTERLEUKIN 3; INTERLEUKIN 6; STEM CELL FACTOR; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; FEMALE; GENE TRANSFER; GENETIC TRANSDUCTION; HEMATOPOIETIC STEM CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; RETROVIRUS; SOUTHERN BLOTTING;

EID: 0031718356     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3300732     Document Type: Article

References (45)

1. Dunbar CE. Gene transfer to hematopoietic stem cells: implications for gene therapy of human disease. Ann Rev Med 1996; 47: 11-20.
2. Brenner MK. Gene transfer to hematopoietic cells. New Engl J Med 1996; 335: 337-339.
3. Bodine DM, Karlsson S, Nienhuis AW. Combination of interleukins 3 and 6 preserves stem cell function in culture and enhances retrovirus-mediated gene transfer into hematopoietic stem cells. Proc Natl Acad Sci USA 1989; 86: 8897-8901.
4. Miller DG, Adam MA, Miller AD. Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection. Mol Cell Biol 1990; 10: 4239-4242.
5. Peters SO, Kittler ELW, Ramshaw HS, Quesenberry PJ. Murine marrow cells expanded in culture with IL-3, IL-6, IL-11, and SCF acquire an engraftment defect in normal hosts. Exp Hematol 1995; 23: 461-466.
6. Spangrude GJ, Brooks DM, Tumas DB. Long-term repopulation of irradiated mice with limiting numbers of purified hematopoietic stem cells: in vivo expansion of stem cell phenotype but not function. Blood 1995; 85, 1006-1016.
7. Hooper WC. The role transforming growth factor-β in hematopoiesis: a review. Leukemia Res 1991; 15: 179-184.
8. Hatzfeld J et al. Release of early human hematopoietic progenitors from quiescence by antisense transforming growth factor β1 or Rb oligonucleotides. J Exp Med 1991; 174: 925-929.
9. Ploemacher RE, van Soest PL, Boudewijn A. Autocrine transforming growth factor beta 1 blocks colony formation and progenitor cell generation by hemopoietic stem cells stimulated with Steel factor. Stem Cells 1993; 11: 336-347.
10. Cashman JD et al. Mechanisms that regulate the cell cycle status of very primitive hematopoietic cells in long-term human marrow cultures. I. Stimulatory role of a variety of mesenchymal cell activators and inhibitory role of TGF-β. Blood 1990; 75: 96-101.
11. Eaves CJ et al. Mechanisms that regulate the cell cycle status of very primitive hematopoietic cells in long-term human marrow cultures. II. Analysis of positive and negative regulators produced by stromal cells within the adherent layer. Blood 1991; 78: 110-115.
12. Soma T, Yu JM, Dunbar CE Maintenance of murine long-term repopulating stem cells in ex vivo culture is affected by modulation of transforming growth factor-β but not macrophage inflammatory protein-la activities. Blood 1996; 87: 4561-4567.
13. Cardoso AA et al. Release from quiescence of CD34 CD38 human umbilical cord blood cells reveals their potentiality to engraft adults. Proc Natl Acad Sci USA 1993; 90: 8707-8711.
14. Waegell WO, Higley HR, Kincade PW, Dasch JR. Growth acceleration and stern cell expansion in Dexter-type cultures by neutralization of TGF-beta. Exp Hematol 1994; 22: 1051-1057.
15. Jacobsen FW, Stokke T, Jacobsen SEW. Transforming growth factor-β potently inhibits the viability-promoting activity of stem cell factor and other cytokines and induces apoptosis of primitive murine hematopoietic progenitor cells. Blood 1995; 86: 2957-2966.
16. Sitnicka E et al. Transforming growth factor β1 directly and reversibly inhibits the initial cell divisions of long-term repopulating hematopoietic stem cells. Blood 1996; 88: 82-88.
17. Hatzfeld A et al. Increased stable retroviral gene transfer in early hematopoietic progenitors released from quiescence. Hum Gene Ther 1996; 7: 207-213.
18. Dunbar CE et al. Retrovirally marked CD34-enriched peripheral blood and bone marrow and cells contribute to long-term engrafrment after autologous transplantation. Blood 1995; 85: 3048-3057.
19. Barker JE, Greer J, Bacon S, Compton ST. Temporal replacement of donor erythrocytes and leukocytes in nonanemic W44j/W44j and severely anemic W/Wv mice. Blood 1991; 78: 1432-1437.
20. Bodine DM, Crosier PS, Clark SC. Effects of hematopoietic growth factors on the survival of primitive stem cells in liquid suspension culture. Blood 1991; 78: 914-920.
21. Jacobsen SEW et al. Ability of flt3 ligand to stimulate the in vitro growth of primitive murine hematopoietic progenitors is potently and directly inhibited by transforming growth factorβ and tumor necrosis factor-α. Blood 1996; 87: 5016-5026.
22. Strife A et al. The effects of transforming growth factor beta 3 on the growth of highly enriched hematopoietic progenitor cells derived from normal human bone marrow and peripheral blood. Cancer Res 1991; 51: 4828-4836.
23. Jacobsen SE, Ruscetti FW, Roberts AB, Keller JR. TGF-beta is a bidirectional modulator of cytokine receptor expression on murine bone marrow cells. Differential effects of TGF-beta 1 and TGF-beta 3. J Immunol 1993; 151: 4534-4544.
24. Carlino JA et al. Transforming growth factor β1 systemically modulates granuloid, erythroid, lymphoid and thrombocytic cells in mice. Exp Hematol 1992; 20: 943-950.
25. Zauli G, Vitale M, Gibellini D, Capitani S. Inhibition of purified CD34- hematopoietic progenitor cells by human immunodeficiency virus 1 or gp120 mediated by endogenous transforming growth factor beta 1. J Exp Med 1996; 183: 99-108.
26. Hatzfeld J et al. Release of early human hematopoietic progenitors from quiescence by antisense transforming growth factor β1 oligonucleotides. J Exp Med 1991; 174: 925-929.
27. Ohishi K et al. Accelerated cell-cycling of hematopoietic progenitors by the flt3 ligand that is modulated by transforming growth factor-β. Blood 1996; 88: 1718-1727.
28. - human umbilical cord blood cells reveals their potentiality to engraft adults. Proc Natl Acad Sci USA 1993; 90: 8707-8711.
29. Zhou JH et al. Cloning and characterization of cDNAs encoding two normal isoforms of bovine stem cell factor. Biochim Biophys Acta 1994; 1223: 148-150.
30. Jacobsen SE et al. Transforming growth factor-β trans-modulates the expression of colony-stimulating factor receptors on murine hematopoietic progenitor cell lines. Blood 1991; 77: 1706-1716.
31. Dubois CM, Ruscetti FW, Stankova J, Keller JR. Transforming growth factor-β regulates c-kit message stability and cell-surface protein expression in hematopoietic progenitors. Blood 1994; 83: 3138-3145.
32. Mekori YA, Metcalfe DD. Transforming growth factor-beta prevents stem cell factor-mediated rescue of mast cells from apoptosis after IL-3 deprivation. J Immunol 1994; 153: 2194-2203.
33. Leary AG, Zeng HQ, Clark SC, Ogawa M. Growth factor requirements for survival in G0 and entry into the cell cycle of primitive human hematopoietic progenitors. Proc Natl Acad Sci USA 1992; 89: 4013-4017.
34. Chaouchi N et al. Characterization of transforming growth factor-beta 1 induced apoptosis in normal human B cells and lymphoma B cell lines. Oncogene 1995; 11: 1615-1622.
35. Alexandrow MG, Moses HL. Transforming growth factor β and cell cycle regulation. Cancer Res 1995; 55: 1452-1457.
36. Ravitz MJ, Wenner CE. Cyclin-dependent kinase regulation during G1 phase and cell cycle regulation by TGF-beta. Adv Cancer Res 1997; 71: 165-207.
37. Hannon GF, Beach D. p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest. Nature 1994; 371: 257-261.
38. Xu LC et al. Poor transduction efficiency of human hematopoietic progenitor cells by a high-titer amphotropic retrovirus producer cell clone. J Virol 1994; 68: 7634-7636.
39. Mardiney M III, Malech HL. Enhanced engraftment of hematopoietic progenitor cells in mice treated with granulocyte colony-stimulating factor before low-dose irradiation: implications for gene therapy. Blood 1996; 87: 4049-4056.
40. Schiffman R et al. Transfer of the human glucocerebrosidase gene into hematopoietic stem cells of nonablated recipients: successful engraftment and long-term expression of the transgene. Blood 1995; 86: 1218-1227.
41. Dunbar C et al. Retrovirus-mediated transfer of the cDNA for human glucocerebrosidase into hematopoietic stem cells of patients with Gaucher disease: a phase 1 study. Hum Gene Ther 1996; 7: 231-253.
42. Malech H et al. Prolonged production of NADPH oxidase-corrected granulocytes after gene therapy of chronic granulomatous disease. Proc Natl Acad Sci USA 1997; 94: 12133-12138.
43. Cassel A, Cottler-Fox M, Doren S, Dunbar CE. Retrovirus-mediated gene transfer into CD34-enriched human peripheral blood stem cells. Exp Hematol 1993; 21: 585-591.
44. Markowitz D, Goff S, Bank A. A safe packaging line for gene transfer: separating viral genes on two different plasmids. J Virol 1988; 62: 1120-1124.
45. Dasch JR et al. Monoclonal antibodies recognizing transforming growth factor-beta. Bioactivity neutralization and transforming growth factor beta 2 affinity purification. J Immunol 1989; 142: 1536-1541.